BIF acquires shares in Calocurb

Page 1 of 1



5 April 2023
Booster Innovation Fund adds Calocurb to its investment portfolio

Booster is pleased to announce the addition of Calocurb to the Booster Innovation Fund (BIF) portfolio.

Calocurb operates in the natural supplement part of the Life Sciences and Medical Technology sector. It
specialises in appetite management, using a unique active ingredient sourced from New Zealand hops
believed to be the only natural, non-prescriptive alternative to highly expensive prescription drugs to
assist people with chronic and debilitating obesity. Calocurb was formed in 2017, and is classified as early
stage, with its technology origins being from Plant and Food Research.

BIF will make a cash investment of $250,000. Following this transaction (and issue of additional units to
fund the purchase), Calocurb will represent 1.7% of BIF’s investment portfolio of 32 companies, and with
a net asset value of over $14.5 million.

Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of
the process described in the fund’s Product Disclosure Statement (PDS) that is available at
www.booster.co.nz

For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-
innovation-fund.aspx





For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300


About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of
the Booster Group which has been helping New Zealanders save since 1998. The group currently
administers superannuation and investment funds of over $5 billion on behalf of more than 170,000 New
Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property
originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement, please visit
www.booster.co.nz